Filtros de búsqueda

Lista de obras de Adriano Lazzarin

48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study

artículo científico publicado en 2016

96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures

artículo científico publicado en 2006

A Controlled Study of Inhaled Pentamidine for Primary Prevention ofPneumocystis cariniiPneumonia

A case of HIV-associated fever of unknown origin: deficit of IL-1β antagonistic activity and resolution with monocyte–granulocyte apheresis

A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markers.

artículo científico publicado en 2017

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.

artículo científico publicado en 2000

A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection

artículo científico publicado en 2002

A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine

artículo científico publicado en 1991

A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settings

artículo científico publicado en 2005

AIDS IN AN ITALIAN DRUG ADDICT

artículo científico publicado en 1984

AIDS, zinc deficiency, and thymic hormone failure

artículo científico publicado en 1988

Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir

artículo científico publicado en 2006

Access denied? The status of co-receptor inhibition to counter HIV entry

artículo científico publicado en 2007

Acute Pancreatitis during Primary HIV-1 Infection

article

Acute ataxia coincident with seroconversion for anti-HIV

article

Acute self-limiting hepatitis C after possible sexual exposure: sequence analysis of the E-2 region of the infected patient and sexual partner.

artículo científico publicado en 2001

Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment

artículo científico publicado en 2007

An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in Europe

artículo científico publicado en 2010

An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection

artículo científico publicado en 2006

An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study.

artículo científico publicado en 2017

Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection

artículo científico publicado en 2002

Anti-CD4 Antibodies in Exposed Seronegative Adults and in Newborns of HIV Type 1-Seropositive Mothers: A Follow-up Study

article

Anti-Cell Antibodies in Exposed Seronegative Individuals with HIV Type 1-Neutralizing Activity

article

Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients

artículo científico publicado en 2013

Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele ⬇️

artículo científico publicado el 4 de agosto de 1997

Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.

artículo científico

Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced disease

artículo científico publicado en 2007

Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a review

artículo científico publicado en 2007

Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.

artículo científico publicado en 2008

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136).

artículo científico publicado en 2009

Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients

artículo científico publicado en 2017

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

artículo científico publicado en 2005

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

artículo científico publicado en 2005

Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials

artículo científico publicado en 2004

Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study

artículo científico publicado en 2014

Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial

artículo científico publicado en 2016

Atazanavir/ritonavir: a valuable once-daily HIV protease inhibitor with little impact on lipid profile

article

Autoantibodies to CD4 in HIV Type 1-Exposed Seronegative Individuals

article

Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets

artículo científico publicado en 2015

Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects.

artículo científico publicado en 1994

Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial

article

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

artículo científico publicado en 2017

Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir-containing regimens

artículo científico publicado en 2013

Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcome

artículo científico publicado en 2004

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service

artículo científico publicado en 2014

CCR2 Polymorphism and HIV Disease

article

CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression.

artículo científico publicado en 2000

CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.

artículo científico publicado en 2000

CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects

artículo científico publicado en 2004

CD30 ligation differentially affects CXCR4-dependent HIV-1 replication and soluble CD30 secretion in non-Hodgkin cell lines and inγ δ T lymphocytes

article

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients

artículo científico publicado en 2017

Central nervous system HIV infection in "less-drug regimen" antiretroviral therapy simplification strategies

artículo científico publicado en 2014

Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection Effect of parenteral treatment with SAMe

article

Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients

artículo científico publicado en 2016

Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patients

artículo científico publicado en 2009

Changes in use of antiretroviral therapy in regions of Europe over time

artículo científico publicado en 1998

Chronic granulomatous disease

artículo científico publicado en 1981

Clinical and immunological aspects of HIV infection in drug addicts.

artículo científico publicado en 1989

Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users

Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations

artículo científico publicado en 2004

Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study

artículo científico publicado en 2013

Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a.

artículo científico publicado en 2004

Comparison of a commercial and an in-house T cell-based assay for the diagnosis of Mycobacterium tuberculosis infection.

artículo científico publicado en 2007

Comparison of a rule-based algorithm with a phenotype-based algorithm for the interpretation of HIV genotypes in guiding salvage regimens in HIV-infected patients by a randomized clinical trial: the mutations and salvage study

artículo científico publicado en 2006

Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection

artículo científico publicado en 2006

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study

artículo científico publicado en 2010

Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

artículo científico publicado en 2004

Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis.

artículo científico publicado en 2001

Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia

artículo científico publicado en 1993

Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: recent data and consensus recommendations

artículo científico publicado en 2006

Coronaviridae and SARS-associated coronavirus strain HSR1.

artículo científico publicado en 2004

Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting

artículo científico publicado en 2013

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients

artículo científico publicado en 2017

Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy

artículo científico publicado en 2016

Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy

artículo científico publicado en 2005

Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing Raltegravir

scientific article published in 2011

Cross-sectional study of community serostatus to highlight undiagnosed HIV infections with oral fluid HIV-1/2 rapid test in non-conventional settings

artículo científico publicado el 31 de marzo de 2013

Cytokines in the acquired immunodeficiency syndrome and other infectious diseases.

artículo científico publicado en 1995

Cytomegalovirus Pneumonia in AIDS Patients

article

Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid

artículo científico publicado el 1 de diciembre de 1992

Darunavir for the treatment of HIV infection

article

Decreased chloroquine sensitivity of Plasmodium falciparum in two Italian travellers from Madagascar.

artículo científico publicado en 1984

Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group.

artículo científico publicado en 2000

Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance

artículo científico publicado en 2002

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study

article

Detection of Pneumocystis carinii and characterization of mutations associated with sulfa resistance in bronchoalveolar lavage samples from human immunodeficiency virus-infected subjects

artículo científico publicado en 2003

Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapy

artículo científico publicado en 2009

Determination of Human Papillomavirus (HPV) Load and Type in High-Grade Cervical Lesions Surgically Resected from HIV-Infected Women during Follow-up of HPV Infection

article

Diagnosis of central nervous system complications in HIV-infected patients

article

Diagnosis of virus-associated opportunistic diseases of the central nervous system in patients with HIV infection by polymerase chain reaction on cerebrospinal fluid.

artículo científico publicado en 1994

Diagnostic and prognostic value of JC virus DNA in plasma in Progressive Multifocal Leukoencephalopathy

artículo científico publicado en 2018

Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy.

artículo científico publicado en 2006

Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjects

artículo científico publicado en 2002

Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study

artículo científico publicado en 2004

Discrete regions of HIV-1 gp41 defined by syncytia-inhibiting affinity-purified human antibodies ⬇️

artículo científico publicado el 1 de febrero de 1993

Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy

artículo científico publicado en 2011

Distribution of natural resistance to NS3 protease inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in genotype 1b of HIV-infected patients.

artículo científico publicado en 2015

Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?

article

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

artículo científico publicado en 2013

Dolutegravir: a new option for HIV treatment

article

Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection

artículo científico publicado en 2003

Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: maraviroc, raltegravir, etravirine

artículo científico publicado en 2011

Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting

artículo científico publicado en 2013

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients

artículo científico publicado en 2017

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

artículo científico publicado en 2005

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug r

artículo científico publicado en 2006

Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin

artículo científico publicado en 2015

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies

artículo científico publicado en 2009

Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.

artículo científico publicado en 2015

Early diagnosis and retention in care of HIV-infected patients through rapid salivary testing: a test-and-treat fast track pilot study

artículo científico publicado en 2016

Effect of Baseline Characteristics on the Efficacy and Safety of Once-Daily Darunavir/ Ritonavir in HIV-1–Infected, Treatment-Naïve ARTEMIS Patients at Week 96

article

Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy.

artículo científico publicado en 2009

Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity

artículo científico publicado en 2007

Effects of endurance exercise training on metabolic and inflammatory parameters in HIV-1-infected patients with secondary lipodystrophy and diabetes

article

Effects of hydroxyurea on T cell count changes during primary HIV infection

article

Efficacy And Safety of Three Doses of Tipranavir Boosted with Ritonavir in Treatment-Experienced HIV Type 1-Infected Patients

article

Efficacy and Safety of Lersivirine (UK-453,061) versus Efavirenz in Antiretroviral Treatment-Naïve HIV-1-Infected Patients

article

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy

artículo científico publicado en 2015

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2007

Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results

artículo científico publicado en 2007

Efficacy and safety of boosted darunavir-based antiretroviral therapy in HIV-1-positive patients: results from a meta-analysis of clinical trials.

artículo científico publicado en 2018

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

artículo científico publicado en 2017

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

artículo científico publicado en 2007

Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a r

artículo científico publicado en 2017

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

artículo científico publicado en 2009

Efficacy and safety of lersivirine (UK-453,061) versus efavirenz in antiretroviral treatment-naive HIV-1-infected patients: week 48 primary analysis results from an ongoing, multicenter, randomized, double-blind, phase IIb trial

artículo científico publicado en 2013

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

artículo científico publicado en 2014

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

artículo científico publicado en 2013

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients

artículo científico publicado en 2017

Efficacy of Raltegravir Versus Efavirenz When Combined With Tenofovir/ Emtricitabine in Treatment-Naïve HIV-1–Infected Patients: Week-192 Overall and Subgroup Analyses From STARTMRK ⬇️

artículo científico publicado el 1 de julio de 2012

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response

artículo científico publicado en 2017

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.

artículo científico publicado en 2016

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia

artículo científico publicado en 2003

Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.

artículo científico publicado en 2001

Efficacy of paroxetine for the treatment of depression in the context of HIV infection.

artículo científico publicado en 1997

Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir

article

Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication ⬇️

artículo científico publicado el 30 de julio de 1998

Enfuvirtide: the first HIV fusion inhibitor

artículo científico publicado en 2005

Enhanced basophil releasability in subjects infected with human immunodeficiency virus ⬇️

artículo científico publicado el 1 de febrero de 1990

Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

artículo científico publicado en 1993

Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma

artículo científico publicado en 2002

Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis

article

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir

artículo científico publicado en 2016

Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy ⬇️

artículo científico publicado el 31 de enero de 2011

Etravirine for the treatment of HIV infection.

artículo científico publicado en 2008

Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir

artículo científico publicado en 2005

Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women

artículo científico publicado en 1998

Evolutionary Characteristics of HIV Type 1 Variants Resistant to Protease Inhibitors in the Absence of Drug-Selective Pressure

article

Ex Vivo Modulation of RANTES and sCD30 by Proinflammatory Stimuli in HIV-Seropositive and -Negative Individuals

article

Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy

artículo científico publicado en 2008

Expression of CD4 on human peripheral blood neutrophils.

artículo científico publicado en 2003

Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease

artículo científico publicado en 2004

Factors Associated with the Development of Opportunistic Infections in HIV‐1–Infected Adults with High CD4+Cell Counts: A EuroSIDA Study

article

Factors Associated with the Development of Pneumocystis carinii Pneumonia in 5,025 European Patients with AIDS

artículo científico publicado en 1995

Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1.

artículo científico publicado en 2007

Fc Receptors Expression and Function in Mononuclear Phagocytes from AIDS Patients: Modulation by IFN-Gamma

article

First Case of Transfusion-Associated AIDS in Italy: A Single Transfusion with a 51-month Latency Period

article

Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine

artículo científico publicado en 2014

GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study

artículo científico publicado en 2005

Ganciclovir Therapy for Cytomegalovirus (CMV) Infection of the Central Nervous System in AIDS Patients: Monitoring by CMV DNA Detection in Cerebrospinal Fluid

article

Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma

artículo científico publicado en 2006

Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns

artículo científico publicado en 2003

Gender, relationship length and the risk of heterosexual HIV transmission

article

Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?

article published in 2017

Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.

artículo científico publicado en 1997

Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment

artículo científico publicado en 2004

Genotypic resistance tests for the clinical management of patients with primary HIV infection

artículo científico publicado en 2003

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group

artículo científico publicado en 2013

Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.

artículo científico publicado en 2010

Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirine

artículo científico publicado en 2013

HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study).

artículo científico publicado en 2012

HEFFICON: HIV Effectiveness Italian Conference.

artículo científico publicado en 2015

HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy

artículo científico publicado en 2016

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients.

artículo científico publicado en 2014

HIV SEROCONVERSION RATES IN INTRAVENOUS DRUG ABUSERS FROM NORTHERN ITALY

artículo científico publicado en 1989

HIV protease inhibitors: present and future

article

HIV-1 AND HIV-2 INFECTIONS IN ITALIAN AIDS/ ARC PATIENTS

artículo científico publicado en 1987

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial

artículo científico publicado en 2015

HIV-1 Tropism Test Evaluation: Assessment and Clinical Implications

article

HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy

scientific article published on 19 May 2020

HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy.

artículo científico publicado en 2008

HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection

article

HIV-related severe thrombocytopenia in intravenous drug users

article

HLA-Associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts

article

HLA-associated susceptibility to HIV-1 infection.

artículo científico publicado en 1992

Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression

artículo científico publicado en 2007

Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluid.

artículo científico publicado en 1998

Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients.

artículo científico publicado en 2005

Highlights on HIV eradication in 2013 ⬇️

artículo científico publicado el 2 de enero de 2014

How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS)

artículo científico publicado en 1997

Human Immunodeficiency Virus Type 1 Glycoprotein 120-Specific T Lymphocytes Provide Intermolecular Help for Anti-CD4 Autoantibody Production in Exposed Uninfected Subjects ⬇️

artículo científico publicado el 20 de noviembre de 1997

Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance.

artículo científico publicado en 1999

Human immunodeficiency virus (HIV) seropositivity in intravenous (i.v.) drug abusers in three cities of Italy: possible natural history of HIV infection in i.v. drug addicts in Italy.

artículo científico publicado en 1987

Human immunodeficiency virus gp120 and p24 oligoclonal antibody in acquired immunodeficiency syndrome cerebrospinal fluid and sera.

artículo científico publicado en 1988

Human immunodeficiency virus type 1 fitness and tropism: concept, quantification, and clinical relevance.

artículo científico publicado en 2010

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

artículo científico publicado en 2001

Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts.

artículo científico publicado en 2009

INOSIPLEX IN RECURRENT HERPES SIMPLEX INFECTIONS

artículo científico publicado en 1982

Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage

artículo científico publicado en 2011

Immortal time bias: authors' reply

artículo científico publicado en 2015

Immune recovery and T cell subset analysis during effective treatment with maraviroc

artículo científico publicado en 2012

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.

artículo científico publicado en 2000

Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patients

artículo científico publicado en 2006

Immunological recovery after 24 weeks of antiretroviral therapy in patients with X4 virus during primary HIV infection

artículo científico publicado en 2014

Immunological status in heroin addicts: Effects of methadone maintenance treatment

scientific article published on 01 March 1984

Immunovirological improvement in partially HAART responder HIV-infected patients by monocyte adsorption apheresis

article

Impact of a treatment including tenofovir plus didanosine on the selection of the 65R mutation in highly drug-experienced HIV-infected patients

artículo científico publicado en 2004

Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection

Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration

article

In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir

artículo científico publicado en 2013

In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users

artículo científico publicado en 1995

In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients

artículo científico publicado en 2005

In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders

artículo científico publicado en 2003

Incidence and Predictors of Serological Treatment Response in Early and Late Syphilis Among People Living With HIV

article

Infection of Circulating CD34+ Cells by HHV-8 in Patients with Kaposi’s Sarcoma

article published in 1999

Integrase and fusion inhibitors transmitted drug resistance in naive patients with recent diagnosis of HIV-1 infection

artículo científico publicado en 2011

Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial.

artículo científico publicado en 1994

Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy

artículo científico publicado en 2002

Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors' reply

artículo científico publicado en 2015

Isolation of spindle-shaped cell populations from primary cultures of Kaposi's sarcoma of different stage

article

Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy.

artículo científico publicado en 2009

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons

artículo científico publicado el 30 de abril de 2011

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011

artículo científico publicado el 31 de marzo de 2012

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015.

artículo científico publicado en 2016

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016.

artículo científico publicado en 2017

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014.

artículo científico publicado en 2015

JC polyomavirus mutants escape antibody-mediated neutralization.

artículo científico publicado en 2015

LEUCOCYTE FUNCTION AFTER ANTENATAL BETAMETHASONE GIVEN TO PREVENT RESPIRATORY DISTRESS

artículo científico publicado en 1977

Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2

article

Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patients

artículo científico publicado en 2004

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).

artículo científico publicado en 2006

Leishmania infection can hamper immune recovery in virologically suppressed HIV-infected patients

artículo científico publicado en 2008

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology

artículo científico

Letter: Phagocyte function in systemic lupus erythematosus ⬇️

artículo científico publicado el 8 de noviembre de 1975

Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels

artículo científico publicado en 2006

Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferases

artículo científico publicado en 2010

Long-Term Remission of HIV-Associated Primary CNS Lymphoma Achieved With Highly Active Antiretroviral Therapy Alone

article

Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression

artículo científico publicado en 2006

Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women

article

Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.

artículo científico publicado en 2018

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials

artículo científico publicado en 2010

Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load

artículo científico publicado en 2018

Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study.

artículo científico publicado en 2010

Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus

artículo científico publicado en 2017

Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens

artículo científico publicado en 2012

Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy

artículo científico publicado en 2000

Long-term response in patients receiving HAART including nelfinavir: experience from two Italian centers.

artículo científico publicado en 2002

Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.

artículo científico publicado en 2011

Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication

artículo científico publicado en 1993

Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance

Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance

Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance

artículo científico publicado en 2004

Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption

article

Lopinavir/ritonavir + tenofovir Dual Therapy versus Lopinavir/ritonavir-Based Triple Therapy in HIV-Infected Antiretroviral Naïve Subjects: The Kalead Study

article

Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine

article by Philippe Sudre et al published December 1997 in Clinical Microbiology and Infection

Lymph Node Finding in Drug Abusers

scientific article published on 01 December 1984

Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruption

artículo científico publicado en 2009

Malignant Lymphoma Related to HIV Infection in Italy: A Report of 46 Cases

artículo científico publicado en 1987

Malignant tumors in patients with human immunodeficiency virus infection: a report of 580 cases.

artículo científico publicado en 1989

Man-to-Woman Sexual Transmission of the Human Immunodeficiency Virus

article published in 1991

Management Strategies for Herpesvirus Infections of the CNS

Management of HIV infection after triple class failure

artículo científico publicado en 2013

Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment

article

Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial

article

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism

artículo científico publicado en 2010

Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting Antiviral Regimens Including Ribavirin

artículo científico publicado en 2015

Maternal predictors of HIV vertical transmission

artículo científico publicado en 1991

Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement

artículo científico publicado el 1 de mayo de 1992

Membrane Expression and Function of Complement Receptors CR1 and CR3 on Neutrophils from HIV-Infected Subjects: Modulation by rTNF-alpha and rGM-CSF

article

Metabolic disorders in a cohort of patients treated with highly aggressive antiretroviral therapies during primary HIV-1 infection

article

Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV-infected person with reactivation of HBV after antiretroviral treatment interruption

article

Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases--an update

artículo científico publicado en 2002

Monocyte-derived macrophage function in HIV-infected subjects: In vitro modulation by rIFN-γ and rGM-CSF

article

Monotherapy With Atazanavir as a Simplificati Strategy

Monotherapy with darunavir/ritonavir or lopinavir/ritonavir versus standard antiretroviral therapy: a randomized clinical trial (2pm Study).

artículo científico publicado en 2016

Mortality of HIV-infected patients with or without cancer: comparison with the general population in Italy

artículo científico publicado en 2011

Mother-to-child transmission of TT virus: sequence analysis of non-coding region of TT virus in infected mother-infant pairs.

artículo científico publicado en 2002

Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction.

artículo científico publicado en 1992

NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human gamma delta lymphocytes

artículo científico publicado en 2008

NS3 protease resistance-associated substitutions in liver tissue and plasma samples from patients infected by hepatitis C virus genotype 1A or 1B.

artículo científico publicado en 2017

Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells

artículo científico publicado en 2007

Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression

artículo científico publicado en 2007

Negative regulation of HIV-1 expression by the natural isoform C-terminus truncated STAT5 (STAT5Δ).

artículo científico publicado en 2006

Neurobrucellosis with spinal cord abscess of the dorsal tract: a case report

artículo científico publicado en 2002

Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretrovirals

artículo científico publicado en 2004

Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals

artículo científico publicado en 2002

Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs

artículo científico publicado en 2013

Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.

artículo científico publicado en 2012

Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals

article

Oligoclonal IgG bands in cerebrospinal fluid and serum during asymptomatic human immunodeficiency virus infection.

artículo científico publicado en 1988

Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO

artículo científico publicado en 2014

Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

artículo científico publicado en 2015

Optimal dietary calcium intake in HIV treated patients: no femoral osteoporosis but higher cardiovascular risk

artículo científico publicado en 2013

Oral CCR5 inhibitors: will they make it through?

artículo científico publicado en 2006

Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.

artículo científico publicado en 2005

Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study ⬇️

artículo científico publicado el 1 de febrero de 1992

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis

artículo científico publicado en 2008

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

artículo científico publicado en 2004

Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients

artículo científico publicado en 2015

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group

artículo científico publicado en 2010

Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset

Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients

artículo científico publicado en 2008

Pharmacokinetics of Zidovudine in HIV-Positive Patients with Liver Disease

article

Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients

artículo científico publicado en 2003

Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis

artículo científico publicado en 2016

Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients

artículo científico publicado en 2013

Pharmacokinetics of the raltegravir/maraviroc/etravirine combination

scientific article published on 04 June 2011

Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 118

artículo científico publicado en 2008

Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up

artículo científico publicado en 2009

Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death

artículo científico publicado en 2014

Plasma Viral Load Concentrations in Women and Men From Different Exposure Categories and With Known Duration of HIV Infection

Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment

artículo científico publicado en 2013

Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome

artículo científico publicado en 1996

Point-of-care testing for HCV infection: recent advances and implications for alternative screening

artículo científico publicado en 2014

Point-of-care testing for hepatitis C virus infection at alternative and high-risk sites: an Italian pilot study in a dental clinic

artículo científico publicado en 2017

Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions

Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients

artículo científico publicado en 1996

Positive modification of injecting behavior among intravenous heroin users from Milan and Northern Italy 1987-1989

article

Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.

artículo científico publicado en 2008

Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial

artículo científico publicado en 2018

Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.

scientific article published on March 2000

Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy

artículo científico publicado en 2010

Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin.

artículo científico publicado en 2005

Predictors of Virological Outcome and Safety in Primary HIV Type 1-Infected Patients Initiating Quadruple Antiretroviral Therapy: QUEST GW PROB3005

article

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

article

Predictors of lack of serological response to syphilis treatment in HIV-infected subjects

artículo científico publicado en 2014

Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy

artículo científico publicado en 2004

Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine.

artículo científico publicado en 2001

Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males

artículo científico publicado en 2017

Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy

artículo científico publicado en 2003

Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy

artículo científico publicado en 2005

Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity

artículo científico publicado en 2011

Pulmonary Candidiasis in a Heroin Addict: Some Remarks on its Aetiology and Pathogenesis

artículo científico publicado en 1985

Raltegravir in treatment naive patients

artículo científico publicado en 2009

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses

artículo científico publicado en 2010

Raltegravir with optimized background therapy for resistant HIV-1 infection

artículo científico publicado en 2008

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

artículo científico publicado en 2010

Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assays

artículo científico publicado en 2003

Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy

artículo científico publicado en 2007

Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.

artículo científico publicado en 2003

Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis

artículo científico publicado en 2003

Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy

artículo científico publicado en 2008

Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis

artículo científico publicado en 2017

Recovery of HIV-related retroviruses from Italian patients with AIDS or AIDS-related complex and from asymptomatic at-risk individuals.

artículo científico publicado en 1987

Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen

artículo científico publicado en 2005

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL

article

Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients

artículo científico publicado en 2004

Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study.

artículo científico publicado en 2002

Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus

artículo científico publicado en 2013

Rheumatoid factors and circulating immune complexes in HIV-infected individuals ⬇️

artículo científico publicado el 1 de diciembre de 1991

Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment.

artículo científico publicado en 2000

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

artículo científico publicado en 2011

Risk behaviour and HTLV-1 seropositivity in injecting drug users

artículo científico publicado en 1990

Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males.

artículo científico publicado en 1990

Risk of Developing AIDS in Newly Seropositive Intravenous Drug Abusers

scientific article published on 01 June 1989

Risk of HIV-related diseases in heterosexuals importing infection from Zaire ⬇️

artículo científico publicado el 1 de marzo de 1988

Risk of human immunodeficiency virus infection in multiple transfused patients.

artículo científico publicado en 1987

Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy

artículo científico publicado en 2012

Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial

article

Role of brain biopsy in the management of focal brain lesions in HIV-infected patients

article

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.

artículo científico publicado en 2017

Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients

artículo científico publicado en 2017

Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study

artículo científico publicado en 2012

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

artículo científico publicado en 2009

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

artículo científico publicado en 2007

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2014

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks

artículo científico publicado en 2005

Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program

artículo científico publicado en 2012

Screening of HIV-1 Isolates by Reverse Heteroduplex Mobility Assay and Identification of Non-B Subtypes in Italy

article

Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection

artículo científico publicado en 2004

Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: short-term and long-term effects on immunological and virological parameters.

artículo científico publicado en 2002

Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients

artículo científico publicado en 2014

Sequencing antiretroviral drugs for long-lasting suppression of HIV replication.

artículo científico publicado en 2005

Serum Polymerase Chain Reaction for Cytomegalovirus DNA for Monitoring Ganciclovir Treatment in AIDS Patients

article

Severe abdominal pain in patients with AIDS: frequency, clinical aspects, causes, and outcome.

artículo científico publicado en 1994

Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score

artículo científico publicado en 2007

Significant link between sCD30 changes and HIV viremia in patients treated with HAART.

artículo científico publicado en 2006

Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results

artículo científico publicado en 2014

Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.

artículo científico publicado en 2017

Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART.

artículo científico publicado en 2016

Spatial working memory in asymptomatic HIV-infected subjects.

artículo científico publicado en 1999

Splenic irradiation versus splenectomy for severe, refractory HIV-related thrombocytopenia: effects on platelet counts and immunological status.

artículo científico publicado en 2000

Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals

artículo científico publicado en 2003

Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients

artículo científico publicado en 2005

Structural skull defects in type IV Ehlers-Danlos syndrome

artículo científico publicado en 1984

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection

artículo científico publicado en 2008

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection

artículo científico publicado en 2008

Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy

artículo científico publicado en 2006

Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failure

artículo científico publicado en 2009

Susac's syndrome as HIV-associated immune reconstitution inflammatory syndrome

artículo científico publicado en 2013

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman

artículo científico publicado en 2014

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study

artículo científico publicado en 2017

Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects

artículo científico publicado en 2007

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.

artículo científico publicado en 2016

TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial

artículo científico publicado en 2005

TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals

artículo científico

Temporal lobe electroencephalogram power modifications during olfactory stimulation in HIV-infected patients.

artículo científico publicado en 1996

Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies

article

The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients

artículo científico publicado en 2006

The Effect of Highly Active Antiretroviral Therapy-Induced Immune Reconstitution on Development and Outcome of Progressive Multifocal Leukoencephalopathy: Study of 43 Cases with Review of the Literature

artículo científico publicado el 1 de enero de 2003

The Efficiency of Male-to Female and Female-to-Male Sexual Transmission of the Human Immunodeficiency Virus

article

The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection

artículo científico publicado el 30 de junio de 2012

The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development

artículo científico publicado en 2005

The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells.

artículo científico publicado en 2001

The effects of the Roche AMPLICOR HIV-1 MONITOR UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisons

artículo científico publicado en 2006

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

artículo científico publicado en 2001

The maraviroc expanded access program - safety and efficacy data from an open-label study

artículo científico publicado en 2015

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

artículo científico publicado en 2014

The preventive phase I trial with the HIV-1 Tat-based vaccine

artículo científico

The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS.

artículo científico publicado en 2002

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

artículo científico publicado en 2007

The therapeutic phase I trial of the recombinant native HIV-1 Tat protein

article

The thymic hormones in the treatment of immune deficiency related to HIV infection

article

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations

artículo científico publicado en 2004

The use of circulating cathodic antigen rapid test and serology for diagnosis of active Schistosoma mansoni infection in migrants in Italy, a non-endemic country: a cross sectional study

artículo científico publicado en 2017

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

artículo científico publicado en 2010

Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients

artículo científico publicado en 2005

Transitory expansion of a CD3+TcR gamma/delta+CD16+ lymphocytic population in two patients with advanced human immunodeficiency virus infection and high levels of natural killer activity.

artículo científico publicado en 1994

Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study

artículo científico publicado en 2008

Transplacental transmission of HTLV-III virus.

artículo científico publicado en 1986

Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

artículo científico publicado en 2002

Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

article

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

artículo científico

Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.

artículo científico publicado en 2002

Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type response

article

Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression

artículo científico publicado en 2014

Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen

artículo científico publicado en 2010

Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutations

artículo científico publicado en 2008

Unusual parenteral HIV transmission

article

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy

artículo científico publicado en 2014

Varicella‐Zoster Virus (VZV) DNA in Cerebrospinal Fluid of Patients Infected with Human Immunodeficiency Virus: VZV Disease of the Central Nervous System or Subclinical Reactivation of VZV Infection? ⬇️

artículo científico publicado el 1 de septiembre de 1997

Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection

article

Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection

artículo científico publicado en 2014

Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study

artículo científico publicado en 2008

Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial

artículo científico publicado en 2010

Virological rebound after suppression on highly active antiretroviral therapy

artículo científico publicado en 2003

Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up.

artículo científico publicado en 2013

Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials

article

Zidovudine and frequency of HIV-induced diffuse leukoencephalopathy ⬇️

artículo científico publicado el 15 de junio de 1991

stARTing cART now! HIV treatment Italian Guidelines Update Dec. 2014.

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda